Chemicals Giant BASF Moves for Rival Evonik — Update
By Najat Kantouar
German chemicals producer BASF said it entered initial talks over a takeover of smaller peer Evonik, a tie-up that would bolster BASF's dominant position in Europe's chemicals industry.
BASF said Friday it was in exploratory takeover talks with Evonik and the latter's largest shareholder, a foundation called RAG-Stiftung. Evonik, a chemicals producer based in Essen, Germany, earlier Friday noted BASF's non-binding approach. RAG-Stiftung, which holds a stake of 43.8% in Evonik, also confirmed the interest from BASF.
None of the companies said how much money BASF was putting on the table for its bid. Evonik's market capitalization stands at 8.42 billion euros ($9.58 billion), according to LSEG data. BASF, the much larger company, has a market cap of some 46.7 billion euros.
The outcome of these talks remains uncertain at this stage, BASF said. The company said it "continuously evaluates" potential acquisitions that could strengthen its core business and fuel growth.
"In doing so, BASF takes a disciplined approach," the company said, adding that it would inform the market of any developments in line with regulatory requirements.
In European late afternoon trading, Evonik shares were up 6.9% at 19.32 euros, while BASF shares traded 4% lower at 50.19 euros.
Write to Najat Kantouar at najat.kantouar@wsj.com
(END) Dow Jones Newswires
September 25, 2026 12:41 ET (16:41 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
